Product Description
Bendamustine HCL For Injection is a chemotherapy drug containing Bendamustine Hydrochloride in powder form for injection. It is specially designed to treat chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma (NHL) in adult cancer patients. The recommended dosage is typically 100 mg/m on Days 1 and 2 of a 28-day cycle, administered intravenously under the supervision of a qualified healthcare provider. Each vial contains 100 mg of Bendamustine Hydrochloride and should be stored below 25C, protected from light and moisture. This allopathic medicine comes in a packaging of 1 vial per box.
FAQs of Bendamustine HCL For Injection:
Q: What is the recommended dosage of Bendamustine HCL For Injection?
A: The recommended dosage is typically 100 mg/m on Days 1 and 2 of a 28-day cycle for adult cancer patients.
Q: How should Bendamustine HCL For Injection be administered?
A: It should be administered intravenously under the supervision of a qualified healthcare provider.
Q: What is the function of Bendamustine HCL For Injection?
A: It is used to treat chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma (NHL).
Q: What is the storage recommendation for this product?
A: It should be stored below 25C, protected from light and moisture.
Q: How many vials are included in each box of Bendamustine HCL For Injection?
A: Each box contains 1 vial of 100 mg Bendamustine Hydrochloride powder.